ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 68 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 3.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $162 | +15.7% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $140 | -0.7% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $141 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +809.1% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 22 | -99.3% | 0.00% | – |
| Q3 2018 | $73,000 | +2.8% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | -2.7% | 3,200 | 0.0% | 0.00% | – |
| Q1 2018 | $73,000 | -13.1% | 3,200 | 0.0% | 0.00% | – |
| Q4 2017 | $84,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | -18.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | +14.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $77,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q4 2016 | $66,000 | +247.4% | 3,200 | +357.1% | 0.00% | – |
| Q3 2016 | $19,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
| Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
| Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
| Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
| TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
| Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
| ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
| THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |